Added to YB: 2025-12-10
Pitch date: 2025-10-09
TECH [bullish]
Bio-Techne Corporation
-10.02%
current return
Author Info
No bio for this author
Company Info
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.
Market Cap
$8.6B
Pitch Price
$59.79
Price Target
59.00 (+10%)
Dividend
0.58%
EV/EBITDA
24.71
P/E
105.67
EV/Sales
7.20
Sector
Life Sciences Tools and Services
Category
growth
Bio-Techne Corporation - $TECH
TECH: Leading life sciences consumables provider with 30-40% cytokines market share, 5% antibodies share. Management targets high-teens EPS CAGR via 5-10% above-market growth through R&D (8% of sales) & acquisitions ($2.1B since 2013). Wilson Wolf acquisition ($1B) likely by 2027. Risks: AI reducing demand, funding environment, goodwill 53% of assets.
Read full article (11 min)